Otsuka Holdings (4578 JP) has revised revenue guidance for 2024 to ¥2,320B from previous ¥2,310B. Pharmaceutical business and nutraceutical business performed strongly.
2024 operating profit guidance have been revised slightly upwards to ¥323B. Due to the impact of temporary tax adjustment in U.S., net profit guidance raised by 43% to ¥343B.
Otsuka shares have rallied 40% in the last one year. With multiple growth drivers at play Otsuka is poised for accelerated growth.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.